Neurosurgical Laboratory for Translational Stem Cell Research,
Weill Cornell Brain Tumor Center,
Neurosurgical Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center
John A. Boockvar has not added Biography.
If you are John A. Boockvar and would like to personalize this page please email our Author Liaison for assistance.
Neural stem cell biology may be well suited for improving brain tumor therapies.
Cancer journal (Sudbury, Mass.) May-Jun, 2003 | Pubmed ID: 12952304
Constitutive EGFR signaling confers a motile phenotype to neural stem cells.
Molecular and cellular neurosciences Dec, 2003 | Pubmed ID: 14697673
Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells.
Neurosurgery , 2005 | Pubmed ID: 15617599
Dural cavernous angioma of the posterior sagittal sinus: case report.
Surgical neurology Feb, 2005 | Pubmed ID: 15680668
The duality of epidermal growth factor receptor (EGFR) signaling and neural stem cell phenotype: cell enhancer or cell transformer?
Current stem cell research & therapy Sep, 2006 | Pubmed ID: 18220882
Use of human neural tissue for the generation of progenitors.
Neurosurgery Jan, 2008 | Pubmed ID: 18300889
Long-term expansion of adult human brain subventricular zone precursors.
Neurosurgery Jan, 2008 | Pubmed ID: 18300911
New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans.
Neurosurgical focus , 2008 | Pubmed ID: 18341405
Brain tumor stem cells: will understanding a new paradigm lead to improved therapies?
Expert review of neurotherapeutics Apr, 2008 | Pubmed ID: 18416652
Stem cell migration in a novel model to study pediatric brain tumors.
Neurosurgery Aug, 2008 | Pubmed ID: 18797346
Disease-specific induced pluripotent stem cells.
Neurosurgery Dec, 2008 | Pubmed ID: 19057305
Stem cell populated implanted trachea.
Neurosurgery May, 2009 | Pubmed ID: 19404132
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.
Brachytherapy Jan-Mar, 2010 | Pubmed ID: 19850535
Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells.
Journal of neuro-oncology May, 2010 | Pubmed ID: 19855928
Stem cell based growth factory delivery to the injured spinal cord.
Neurosurgery Feb, 2010 | Pubmed ID: 20087121
Interstitial infusion of erlotinib in the rodent brain.
Journal of experimental therapeutics & oncology , 2009 | Pubmed ID: 20192114
Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.
Journal of experimental therapeutics & oncology , 2009 | Pubmed ID: 20192120
Forcing tumor stem cells to an end.
Neurosurgery Apr, 2010 | Pubmed ID: 20305479
High-viscosity polymethylmethacrylate cement for endoscopic anterior cranial base reconstruction.
Journal of neurosurgery Nov, 2010 | Pubmed ID: 20345225
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection.
Journal of cancer research and therapeutics Jan-Mar, 2010 | Pubmed ID: 20479550
Neural stem cells: targeting glioma in 3-dimensions.
Neurosurgery Jun, 2010 | Pubmed ID: 20495412
Results and risk factors for recurrence following single-level tubular lumbar microdiscectomy.
Journal of neurosurgery. Spine Jun, 2010 | Pubmed ID: 20515355
Pineal parenchymal tumor of intermediate differentiation with papillary features: a continuum of primary pineal tumors?
Journal of neuro-oncology Jan, 2011 | Pubmed ID: 20521161
EGFR signaling is differentially activated in patient-derived glioblastoma stem cells.
Journal of experimental therapeutics & oncology , 2010 | Pubmed ID: 20734923
Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.
Journal of neuro-oncology Jul, 2011 | Pubmed ID: 20853017
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.
Journal of neurosurgery Mar, 2011 | Pubmed ID: 20964595
Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction.
Journal of neuro-oncology Sep, 2011 | Pubmed ID: 21336775
Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Neurosurgical focus Apr, 2011 | Pubmed ID: 21456921
Neural stem cells and glioma stem-like cells respond differently to chemotherapeutic drugs: selectivity at the cellular level.
Neurosurgery Jun, 2011 | Pubmed ID: 21778947
Glioblastoma Stem-Like Cells-Biology and Therapeutic Implications.
Cancers Jun, 2011 | Pubmed ID: 21796273
Direct conversion of human fibroblasts to functional neurons in one step.
Neurosurgery Dec, 2011 | Pubmed ID: 22067346
Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme.
Journal of experimental therapeutics & oncology , 2011 | Pubmed ID: 22070049
The Contribution of Notch Signaling to Glioblastoma via Activation of Cancer Stem Cell Self-renewal: The Role of the Endothelial Network.
Neurosurgery Feb, 2012 | Pubmed ID: 22251985
Protein Phosphatase 2A Mediates Dormancy of Glioblastoma Multiforme-Derived Tumor Stem-Like Cells during Hypoxia.
PloS one , 2012 | Pubmed ID: 22253878
Kevin Wong1,
Angel Ayuso-Sacido2,3,
Patrick Ahyow1,
Andrew Darling4,
John A. Boockvar2,
Mingming Wu4
1Biomedical Engineering Department, Cornell University,
2Neurosurgical Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Weill Cornell Medical College of Cornell University,
3Cell Morphology Department, Instituto de Investigacion Principe Felipe,
4Department of Chemical and Biomolecular Engineering, Cornell University
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados